在印度,MISHTI研究评估了2型糖尿病患者的肝纤维化
Debasis Datta1, Krishna G Seshadri2, Samit Ghosal3
1Fortis Hospital, Kolkata, India.
Scientific reports
|July 9, 2025
概括
纤维化4指数 (FIB 4) 评分显示在2型糖尿病 (T2D) 患者中检测肝纤维化的灵敏度高,但特异性低. 体重指数 (BMI),AST和HbA1c是T2D中纤维化的主要预测指标.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
- 诊断的准确性 诊断的准确性
背景情况:
- 肝纤维化是代谢障碍的严重并发症,特别是在2型糖尿病 (T2D) 中.
- 精确检测显著的肝纤维化对于管理T2D相关的肝病至关重要.
研究的目的:
- 评估纤维化4指数 (FIB 4) 在确定T2D患者显著肝纤维化的表现.
- 通过逻辑回归来确定T2D中显著肝纤维化的主要临床预测因素.
主要方法:
- 一项涉及三家印度三级保健中心倾向匹配的T2D和非T2D患者 (n=472) 的横截面研究.
- 评估FIB 4评分和使用灵敏度,特异性和Cohen's Kappa的瞬态弹性学 (TE) 之间的一致性.
- 使用后勤回归和ROC曲线来识别纤维化预测因子并评估模型性能.
主要成果:
- 在T2D患者中,FIB 4评分表现出高灵敏度 (85.3%),但特异性较差 (13.7%),与TE没有一致 (科恩的卡帕 -0.01).
- 在非T2D患者 (47.2%,卡帕0.16) 中,特异性得到改善.
- 后勤回归确定BMI,高血压和HbA1c作为T2D的重要预测因素. 一个包括男性性别,BMI,AST和HbA1c的精细模型实现了0.735.5的AUC.
结论:
- 由于特异性较低,FIB 4指数作为T2D中显著肝纤维化的独立诊断工具的实用性有限.
- 体重指数,AST和HbA1c是T2D患者肝纤维化的关键预测指标.
- 将非侵入性标记物与临床数据相结合,对于准确的风险分层和管理代谢相关脂肪性肝病 (MASLD) 是必不可少的.
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
01:26Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
01:19Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17